SCHEMBL2911992

SCHEMBL2911992

Nc1nc(NCCCn2cc(NC(=O)CN3CCC(C(=O)O)CC3)c(-c3ccc(Cl)cc3Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.46
GSK3A P49840 3/20 0.46
CDK1 P06493 2/20 0.41
CCNB2 O95067 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
POLB P06746 2/20 0.37
ALDH1A1 P00352 5/20 0.36
RECQL P46063 1/20 0.36
F10 P00742 1/20 0.35
MAPK1 P28482 2/20 0.35
TERT O14746 1/20 0.35
ATM Q13315 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PTGDR Q13258 1/20 0.34
KDM4E B2RXH2 2/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907595 0.95 GSK3B (0.46) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2912784 0.92 GSK3B (0.49) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910746 0.91 GSK3B (0.48) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2908076 0.90 GSK3B (0.44) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2914179 0.90 GSK3B (0.47) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909848 0.88 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911693 0.88 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2909820 0.88 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2911760 0.88 GSK3B (0.45) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2903975 0.85 POLB (0.39) GSK3BGSK3APOLBALDH1A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed